Jason Raasch, MD
Allergy & Immunology · Plymouth, MNNPI 1811095854
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Pharming Healthcare, Inc. accounts for 63.5% of it on its own, with 31 other manufacturers making up the rest. 2025 is the largest year on record at $68,264, more than ten times the $37 reported in 2019. Among allergy & immunology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 264 payments — averaging $577.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharming Healthcare, Inc.$97K
- Consortium Of Independent Immunology Clinics, LLC$26K
- CSL Behring$13K
- Ionis Pharmaceuticals, Inc.$10K
- ADMA Biomanufacturing LLC$4K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- plus $2K from 26 others
Across 146 payments — averaging $14,105 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$1.8M
- GSK$148K
- Kedrion S.p.a.$40K
- CSL Behring$18K
- Viiv Healthcare Company$13K
- Shire North American Group Inc$6K
- plus $4K from 2 others
Across 2 payments — averaging $4265.50 each. An ownership or investment interest held by the physician or an immediate family member.
- Consortium Of Independent Immunology Clinics, LLC$9K
What the payments were for
- Consulting fees$85,01156%
- Speaking & faculty fees$48,75132%
- Travel & lodging$13,7859%
- Food & beverage$4,9643%
- Education$620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharming Healthcare, Inc. | 129 | $96,883 |
| Consortium Of Independent Immunology Clinics, LLC | 3 | $25,953 |
| CSL Behring | 30 | $12,800 |
| Ionis Pharmaceuticals, Inc. | 13 | $9,610 |
| ADMA Biomanufacturing LLC | 10 | $4,024 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $1,658 |
| Blueprint Medicines Corporation | 3 | $216 |
| Pfizer | 11 | $175 |
| Octapharma USA, Inc. | 6 | $171 |
| Amgen(2 entities) | 5 | $149 |
| GSK | 9 | $132 |
| Tersera Therapeutics LLC | 2 | $119 |
| Genentech USA, Inc. | 3 | $117 |
| Bio Products Laboratory USA, Inc. | 6 | $84 |
| Cycle Pharmaceuticals Inc | 3 | $70 |
| Biocryst US Sales Co., LLC | 3 | $58 |
| AstraZeneca | 4 | $56 |
| AbbVie(2 entities) | 3 | $50 |
| Biomerieux Inc | 1 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $23 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Baxter Healthcare | 1 | $23 |
| Kedrion Biopharma, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $17 |
| GC Biopharma USA, Inc. | 1 | $16 |
| Hospira, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Biogen | 1 | $14 |
| Novartis | 1 | $14 |
| Grifols USA, LLC | 1 | $12 |
| Organon | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$152,574 in reported general payments places this provider in the 95th percentile of 57 allergy & immunology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TakhzyroLanadelumab-Flyo | 14 | $717,260 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 21 | $192,379 |
| CutaquigImmun Glob G(Igg)-Hipp/Maltose | 20 | $99,889 |
| CuvitruImmun Glob G(Igg)/Gly/Iga Ov50 | 18 | $77,347 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 12 | $31,107 |
| Azithromycin | 28 | $431 |
| Amoxicillin | 19 | $243 |
| Prednisone | 16 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Takhzyro, Cuvitru | $1,658 | $794,60732 claims |
| CSL BehringHizentra | $12,800 | $192,37921 claims |
| Octapharma USA, Inc.Cutaquig | $171 | $99,88920 claims |
| Grifols USA, LLCGamunex-C | $12 | $31,10712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 57 allergy & immunology providers in Minnesota.
Other allergy & immunology in Plymouth
- Ralph ShapiroPlymouth$8K
- Nicole ChaseSaint Paul$1.8M
- Thanai PongdeeRochester$58K
- Elina JerschowRochester$45K
- Nancy OttMinneapolis$23K
- David LoweRochester$18K
- Srinivasan RamanujaMankato$18K
- Douglas McMahonMaplewood$18K
- Niladri AichbhaumikSaint Paul$15K
- Dayne VoelkerRochester$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.